Abstract:The deregulation of epigenetic pathways has been implicated as a critical step in tumorigenesis including in childhood brain tumor medulloblastoma. The H3K27me3 demethylase UTX/KDM6A plays important roles in development and is frequently mutated in various types of cancer. However, how UTX regulates tumor development remains largely unclear. Here, we report the generation of a UTX-deleted mouse model of SHH medulloblastoma that demonstrates the tumor suppressor functions of UTX, which could be antagonized by the deletion of another H3K27me3 demethylase JMJD3/KDM6B. Intriguingly, UTX deletion in cancerous cerebellar granule neuron precursors (CGNPs) resulted in the impaired recruitment of host CD8+ T cells to the tumor microenvironment through a non-cell autonomous mechanism. In both mouse medulloblastoma models and in human medulloblastoma cells, we showed that UTX activates Th1-type chemokines, which are responsible for T cell migration. Surprisingly, our results showed that the depletion of cytotoxic CD8+ T cells did not affect mouse medulloblastoma growth. Nevertheless, the UTX/chemokine/T cell recruitment pathway we identified may be applied to many other cancers and may be important for improving cancer immunotherapy. In addition, UTX is required for the expression of NeuroD2 in precancerous progenitors, which encodes a potent proneural transcription factor. Overexpression of NEUROD2 in CGNPs decreased cell proliferation and increased neuron differentiation. We showed that UTX deletion led to impaired neural differentiation, which could coordinate with active SHH signaling to accelerate medulloblastoma development. Thus, UTX regulates both cell-intrinsic oncogenic processes and the tumor microenvironment in medulloblastoma. Our study provides insights into both medulloblastoma development and context dependent functions of UTX in tumorigenesis.

UTX Condensation Underlies Its Tumour-Suppressive Activity.

Protein condensates provide a platform for controlling chromatin

UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs

CUL4B-DDB1-COP1-mediated UTX Downregulation Promotes Colorectal Cancer Progression.

UTX Inhibition As Selective Epigenetic Therapy Against TAL1-driven T-cell Acute Lymphoblastic Leukemia

The Histone H3 Lysine-27 Demethylase UTX Plays a Critical Role in Colorectal Cancer Cell Proliferation

Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma

The tumor-maintaining function of UTX/KDM6A in DNA replication and the PARP1-dependent repair pathway

Alternative mRNA Splicing Controls the Functions of the Histone H3K27 Demethylase UTX/KDM6A

UTX Promotes Hormonally Responsive Breast Carcinogenesis Through Feed-Forward Transcription Regulation with Estrogen Receptor.

Hydroxyphenylpyruvate Dioxygenase is a Metabolic Immune Checkpoint for UTX-deficient Colorectal Cancer.

Utx loss causes myeloid transformation

Ubiquitous Expressed Transcript Promotes Tumorigenesis by Acting As a Positive Modulator of the Polycomb Repressive Complex 2 in Clear Cell Renal Cell Carcinoma

UTX regulates mesoderm differentiation of embryonic stem cells independent of H3K27 demethylase activity

In Vivo CRISPR Screening Unveils Histone Demethylase UTX As an Important Epigenetic Regulator in Lung Tumorigenesis.

X-linked H3K27me3 demethylase Utx is required for embryonic development in a sex-specific manner

UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development

Perturbing TET2 condensation promotes aberrant genome-wide DNA methylation and curtails leukaemia cell growth

Loss of GATA6-mediated up-regulation of UTX promotes pancreatic tumorigenesis and progression

Histone H3K27 Demethylases and Tumorigenesis

Drosophila UTX Coordinates with P53 to Regulate Ku80 Expression in Response to DNA Damage.